---
pmid: '26267536'
title: Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy.
authors:
- Ronca R
- Giacomini A
- Di Salle E
- Coltrini D
- Pagano K
- Ragona L
- Matarazzo S
- Rezzola S
- Maiolo D
- Torrella R
- Moroni E
- Mazzieri R
- Escobar G
- Mor M
- Colombo G
- Presta M
journal: Cancer Cell
year: '2015'
full_text_available: false
doi: 10.1016/j.ccell.2015.07.002
---

# Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy.
**Authors:** Ronca R, Giacomini A, Di Salle E, Coltrini D, Pagano K, Ragona L, Matarazzo S, Rezzola S, Maiolo D, Torrella R, Moroni E, Mazzieri R, Escobar G, Mor M, Colombo G, Presta M
**Journal:** Cancer Cell (2015)
**DOI:** [10.1016/j.ccell.2015.07.002](https://doi.org/10.1016/j.ccell.2015.07.002)

## Abstract

1. Cancer Cell. 2015 Aug 10;28(2):225-39. doi: 10.1016/j.ccell.2015.07.002.

Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy.

Ronca R(1), Giacomini A(2), Di Salle E(2), Coltrini D(2), Pagano K(3), Ragona 
L(3), Matarazzo S(2), Rezzola S(2), Maiolo D(4), Torrella R(5), Moroni E(5), 
Mazzieri R(6), Escobar G(7), Mor M(8), Colombo G(5), Presta M(9).

Author information:
(1)Department of Molecular and Translational Medicine, University of Brescia, 
25123 Brescia, Italy. Electronic address: roberto.ronca@unibs.it.
(2)Department of Molecular and Translational Medicine, University of Brescia, 
25123 Brescia, Italy.
(3)NMR Laboratory, Istituto per lo Studio delle Macromolecole, CNR, 20133 Milan, 
Italy.
(4)Chemistry for Technologies Laboratory and INSTM, School of Engineering, 
University of Brescia, 25123 Brescia, Italy.
(5)Istituto di Chimica del Riconoscimento Molecolare, CNR, 20133 Milan, Italy.
(6)University of Queensland Diamantina Institute, Translational Research 
Institute, Brisbane, QLD 4102, Australia.
(7)San Raffaele Telethon Institute for Gene Therapy, 20132 Milan, Italy; Vita 
Salute San Raffaele University, 20132 Milan, Italy.
(8)Department of Pharmacy, University of Parma, 43121 Parma, Italy.
(9)Department of Molecular and Translational Medicine, University of Brescia, 
25123 Brescia, Italy. Electronic address: marco.presta@unibs.it.

Comment in
    Nat Rev Drug Discov. 2015 Oct;14(10):680. doi: 10.1038/nrd4747.

The fibroblast growth factor (FGF)/FGF receptor (FGFR) system plays a crucial 
role in cancer by affecting tumor growth, angiogenesis, drug resistance, and 
escape from anti-angiogenic anti-vascular endothelial growth factor therapy. The 
soluble pattern recognition receptor long-pentraxin 3 (PTX3) acts as a multi-FGF 
antagonist. Here we demonstrate that human PTX3 overexpression in transgenic 
mice driven by the Tie2 promoter inhibits tumor growth, angiogenesis, and 
metastasis in heterotopic, orthotopic, and autochthonous FGF-dependent tumor 
models. Using pharmacophore modeling of the interaction of a minimal 
PTX3-derived FGF-binding pentapeptide with FGF2, we identified a small-molecule 
chemical (NSC12) that acts as an extracellular FGF trap with significant 
implications in cancer therapy.

Copyright Â© 2015 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.ccell.2015.07.002
PMID: 26267536 [Indexed for MEDLINE]
